Background Hyperinsulinemia is independently associated with increased risk and mortality of pancreatic cancer. We recently reported that genetically reduced insulin production resulted in ~ 50% suppression of pancreatic intraepithelial neoplasia (PanIN) precancerous lesions in mice. However, only female mice remained normoglycemic, and only the gene dosage of the rodent-specific Ins1 alleles was tested in our previous model. Moreover, we did not delve into the molecular and cellular mechanisms associated with modulating hyperinsulinemia. Methods We studied how reduced Ins2 gene dosage affects PanIN lesion development in both male and female Ptf1aCreER;KrasLS...
<div><p>Epidemiologic data has linked obesity to a higher risk of pancreatic cancer, but the underly...
Hyperinsulinaemia, obesity and dyslipidaemia are independent and collective risk factors for many ca...
Hyperinsulinemia could have a role in the growing incidence of esophageal adenocarcinoma (EAC) and i...
Pancreatic ductal adenocarcinoma (PDAC) is the 3rd leading cause of cancer death in Canada and its i...
Pancreatic ductal adenocarcinoma (PDAC) is the 3rd leading cause of cancer death in Canada and its i...
Obesity and early-stage type 2 diabetes (T2D) increase the risk for many cancers, including pancreat...
Obesity and early-stage type 2 diabetes (T2D) increase the risk for many cancers, including pancreat...
Obesity is one of the biggest health concerns around the world and is closely associated with insuli...
SummaryHyperinsulinemia is associated with obesity and pancreatic islet hyperplasia, but whether ins...
Epidemiological studies have reported positive correlation between type 2 diabetes and risk of pancr...
Hyperinsulinaemia, obesity and dyslipidaemia are independent and collective risk factors for many ca...
Hyperinsulinemia, obesity and dyslipidemia are independent and collective risk factors for many canc...
Hyperinsulinaemia, obesity and dyslipidaemia are independent and collective risk factors for many ca...
Diabetes mellitus is a well-known risk factor for pancreatic cancer. We focused on hyperglycemia, a ...
SummaryHyperinsulinemia is associated with obesity and pancreatic islet hyperplasia, but whether ins...
<div><p>Epidemiologic data has linked obesity to a higher risk of pancreatic cancer, but the underly...
Hyperinsulinaemia, obesity and dyslipidaemia are independent and collective risk factors for many ca...
Hyperinsulinemia could have a role in the growing incidence of esophageal adenocarcinoma (EAC) and i...
Pancreatic ductal adenocarcinoma (PDAC) is the 3rd leading cause of cancer death in Canada and its i...
Pancreatic ductal adenocarcinoma (PDAC) is the 3rd leading cause of cancer death in Canada and its i...
Obesity and early-stage type 2 diabetes (T2D) increase the risk for many cancers, including pancreat...
Obesity and early-stage type 2 diabetes (T2D) increase the risk for many cancers, including pancreat...
Obesity is one of the biggest health concerns around the world and is closely associated with insuli...
SummaryHyperinsulinemia is associated with obesity and pancreatic islet hyperplasia, but whether ins...
Epidemiological studies have reported positive correlation between type 2 diabetes and risk of pancr...
Hyperinsulinaemia, obesity and dyslipidaemia are independent and collective risk factors for many ca...
Hyperinsulinemia, obesity and dyslipidemia are independent and collective risk factors for many canc...
Hyperinsulinaemia, obesity and dyslipidaemia are independent and collective risk factors for many ca...
Diabetes mellitus is a well-known risk factor for pancreatic cancer. We focused on hyperglycemia, a ...
SummaryHyperinsulinemia is associated with obesity and pancreatic islet hyperplasia, but whether ins...
<div><p>Epidemiologic data has linked obesity to a higher risk of pancreatic cancer, but the underly...
Hyperinsulinaemia, obesity and dyslipidaemia are independent and collective risk factors for many ca...
Hyperinsulinemia could have a role in the growing incidence of esophageal adenocarcinoma (EAC) and i...